New study aims to sharpen diagnosis of rare nerve disease
NCT ID NCT06617962
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study looks at two different lab tests to see which one is better at diagnosing a rare autoimmune disease called MOGAD, which affects the nerves. Researchers will test 240 adults who are suspected of having MOGAD, as well as people with other nerve conditions, to compare the accuracy of the two tests. The goal is to improve diagnosis and help doctors choose the right treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huashan Hospital
RECRUITINGShanghai, Shanghai Municipality, 200040, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.